November 8, 2021 – Dispelix, a provider of lightweight single-layer waveguides and see-through displays for augmented reality (AR) devices, has today announced that it has closed a USD $33 million Series-B funding round led by Atlantic Bridge alongside new investors CCB Trust and Flashpoint. All existing investors including Lifeline Ventures, VTT Ventures, Finnish Industry Investment and 3M Ventures also participated in this round, bringing the company’s total funding to date to USD $50 million.
“Our patented see-through display technology is the key enabler for augmented reality devices such as smart-glasses where weight, display quality and form factor are key attributes. These can be best realized by feather-weight single-layer optics which is our unique forte and we are now gearing to scale these capabilities for mass production for our customers forthcoming consumer offerings” said Antti Sunnari, co-founder and CEO of Dispelix. “This new investment will allow us to serve more OEM customers better and faster, as their trusted and dedicated waveguide partner.”
Also commenting on the investment, Paul Murray, Partner with Atlantic Bridge, said: “We invested in Dispelix as they have a unique mix of technologies that delivers a superior end-user experience for mixed reality smart-glasses and other AR devices – offering the lightest, lowest power and highest resolution displays.” He continued, “Their ability to scale these benefits for their growing list of OEMs will be a key enabler in the adoption of next generation mixed reality platforms and to help deliver on the promise of the Metaverse”
Dispelix stated that with 43 granted or pending patent families currently being integrated into an increasing number of consumer products under development by the company’s OEM customers, product offerings featuring its hardware solutions are expected to hit the market during 2023.
For more information on Dispelix and its diffractive single layer, full color waveguide displays, please visit the company’s website.
Image credit: Dispelix